e83 |
The power of the Risk of Ovarian Malignancy Algorithm considering menopausal status: a comparison with CA 125 and HE4The power of the Risk of Ovarian Malignancy Algorithm considering menopausal status: a comparison with CA 125 and HE4
Kyung Hee Han, Noh Hyun Park, Jin Ju Kim, Sunmie Kim, Hee Seung Kim, Maria Lee, Yong Sang SongKyung Hee Han, Noh Hyun Park, Jin Ju Kim, Sunmie Kim, Hee Seung Kim, Maria Lee, Yong Sang Song
KMSID: 1134472 J Gynecol Oncol. 2019;30(6):e83. Published online 2019 May 20 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e83 |
|
e85 |
Prognostic value of neutrophil-to-lymphocyte ratio in early-stage ovarian clear-cell carcinomaPrognostic value of neutrophil-to-lymphocyte ratio in early-stage ovarian clear-cell carcinoma
Kosuke Yoshida, Nobuhisa Yoshikawa, Akira Shirakawa, Kaoru Niimi, Shiro Suzuki, Hiroaki Kajiyama, Fumitaka KikkawaKosuke Yoshida, Nobuhisa Yoshikawa, Akira Shirakawa, Kaoru Niimi, Shiro Suzuki, Hiroaki Kajiyama, Fumitaka Kikkawa
KMSID: 1134473 J Gynecol Oncol. 2019;30(6):e85. Published online 2019 April 22 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e85 |
|
e88 |
A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3
Young-Chul Park, Yung-Taek Ouh, Moon-Hee Sung, Hong-Gyu Park, Tae-Jin Kim, Chi-Heum Cho, Jong Sup Park, Jae-Kwan LeeYoung-Chul Park, Yung-Taek Ouh, Moon-Hee Sung, Hong-Gyu Park, Tae-Jin Kim, Chi-Heum Cho, Jong Sup Park, Jae-Kwan Lee
KMSID: 1134474 J Gynecol Oncol. 2019;30(6):e88. Published online 2019 May 2 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e88 |
|
e89 |
Prognostic value of metabolic tumor volume and total lesion glycolysis from 18 F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinomaPrognostic value of metabolic tumor volume and total lesion glycolysis from 18 F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma
Dou-dou Liu, Jianfang Li, Xiaomao Li, Liangjun Xie, Luping Qin, Fangyu Peng, Mu-hua ChengDou-dou Liu, Jianfang Li, Xiaomao Li, Liangjun Xie, Luping Qin, Fangyu Peng, Mu-hua Cheng
KMSID: 1134475 J Gynecol Oncol. 2019;30(6):e89. Published online 2019 November 4 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e89 |
|
e90 |
Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patientsLong-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients
Akira Mitsuhashi, Yuji Habu, Tatsuya Kobayashi, Yoshimasa Kawarai, Hiroshi Ishikawa, Hirokazu Usui, Makio ShozuAkira Mitsuhashi, Yuji Habu, Tatsuya Kobayashi, Yoshimasa Kawarai, Hiroshi Ishikawa, Hirokazu Usui, Makio Shozu
KMSID: 1134476 J Gynecol Oncol. 2019;30(6):e90. Published online 2019 May 20 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e90 |
|
e93 |
Evaluation of non-completion of intraperitoneal chemotherapy in patients with advanced epithelial ovarian cancerEvaluation of non-completion of intraperitoneal chemotherapy in patients with advanced epithelial ovarian cancer
Laura Moulton Chambers, Ji Son, Milena Radeva, Robert DeBernardoLaura Moulton Chambers, Ji Son, Milena Radeva, Robert DeBernardo
KMSID: 1134477 J Gynecol Oncol. 2019;30(6):e93. Published online 2019 May 22 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e93 |
|
e94 |
Investigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experienceInvestigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experience
Alice Indini, Lorenza Di Guardo, Carolina Cimminiello, Domenica Lorusso, Francesco Raspagliesi, Michele Del VecchioAlice Indini, Lorenza Di Guardo, Carolina Cimminiello, Domenica Lorusso, Francesco Raspagliesi, Michele Del Vecchio
KMSID: 1134478 J Gynecol Oncol. 2019;30(6):e94. Published online 2019 May 13 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e94 |
|
e95 |
Accuracy of frozen section diagnosis and factors associated with final pathological diagnosis upgrade of mucinous ovarian tumorsAccuracy of frozen section diagnosis and factors associated with final pathological diagnosis upgrade of mucinous ovarian tumors
Jeong-Yeol Park, Sang-Hun Lee, Kyu-Rae Kim, Young-Tak Kim, Joo-Hyun NamJeong-Yeol Park, Sang-Hun Lee, Kyu-Rae Kim, Young-Tak Kim, Joo-Hyun Nam
KMSID: 1134479 J Gynecol Oncol. 2019;30(6):e95. Published online 2019 November 4 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e95 |
|
e96 |
Relationship between the precursors of high grade serous ovarian cancer and patient characteristics: decreased incidence of the p53 signature in pregnant womenRelationship between the precursors of high grade serous ovarian cancer and patient characteristics: decreased incidence of the p53 signature in pregnant women
Tsutomu Ida, Hiroyuki Fujiwara, Takahiro Kiriu, Yoshimi Taniguchi, Akira KohyamaTsutomu Ida, Hiroyuki Fujiwara, Takahiro Kiriu, Yoshimi Taniguchi, Akira Kohyama
KMSID: 1134480 J Gynecol Oncol. 2019;30(6):e96. Published online 2019 June 3 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e96 |
|
e99 |
Concurrence of ovarian cancer and dermatomyositis: a propensity score analysisConcurrence of ovarian cancer and dermatomyositis: a propensity score analysis
Hongyan Cheng, Lanqing Huo, Dan Wang, Yang XiangHongyan Cheng, Lanqing Huo, Dan Wang, Yang Xiang
KMSID: 1134481 J Gynecol Oncol. 2019;30(6):e99. Published online 2019 June 10 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e99 |
|
e100 |
The efficacy of secondary cytoreductive surgery for recurrent ovarian, tubal, or peritoneal cancer in Tian-model low-risk patientsThe efficacy of secondary cytoreductive surgery for recurrent ovarian, tubal, or peritoneal cancer in Tian-model low-risk patients
Makiko So, Taito Miyamoto, Ryusuke Murakami, Kaoru Abiko, Junzo Hamanishi, Tsukasa Baba, Masaki MandaiMakiko So, Taito Miyamoto, Ryusuke Murakami, Kaoru Abiko, Junzo Hamanishi, Tsukasa Baba, Masaki Mandai
KMSID: 1134459 J Gynecol Oncol. 2019;30(6):e100. Published online 2019 June 10 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e100 |
|
e102 |
Prognostic factors and effects of fertility-sparing surgery in women of reproductive age with ovarian clear-cell carcinoma: a propensity score analysisPrognostic factors and effects of fertility-sparing surgery in women of reproductive age with ovarian clear-cell carcinoma: a propensity score analysis
Masato Yoshihara, Hiroaki Kajiyama, Satoshi Tamauchi, Shiro Suzuki, Kunihiko Takahashi, Shigeyuki Matsui, Fumitaka KikkawaMasato Yoshihara, Hiroaki Kajiyama, Satoshi Tamauchi, Shiro Suzuki, Kunihiko Takahashi, Shigeyuki Matsui, Fumitaka Kikkawa
KMSID: 1134460 J Gynecol Oncol. 2019;30(6):e102. Published online 2019 June 26 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e102 |
|
e103 |
Clinicopathologic features, treatment, prognosis and prognostic factors of neuroendocrine carcinoma of the endometrium: a retrospective analysis of 42 cases from the Kansai Clinical Oncology Group/Intergroup study in JapanClinicopathologic features, treatment, prognosis and prognostic factors of neuroendocrine carcinoma of the endometrium: a retrospective analysis of 42 cases from the Kansai Clinical Oncology Group/Intergroup study in Japan
Harunobu Matsumoto, Mototsugu Shimokawa, Kaei Nasu, Ayumi Shikama, Takaya Shiozaki, Masayuki Futagami, Kentaro Kai, Hiroaki Nagano, Taisuke Mori, Mitsutake Yano, Norihiro Sugino, Etsuko Fujimoto, Norihito Yoshioka, Satoshi Nakagawa, Muneaki Shimada, Hideki Tokunaga, Yuki Yamada, Tomohiko Tsuruta, Kazuto Tasaki, Ryutaro Nishikawa, Shiho Kuji, Takashi Motohashi, Kimihiko Ito, Takashi Yamada, Norihiro TeramotoHarunobu Matsumoto, Mototsugu Shimokawa, Kaei Nasu, Ayumi Shikama, Takaya Shiozaki, Masayuki Futagami, Kentaro Kai, Hiroaki Nagano, Taisuke Mori, Mitsutake Yano, Norihiro Sugino, Etsuko Fujimoto, Norihito Yoshioka, Satoshi Nakagawa, Muneaki Shimada, Hideki Tokunaga, Yuki Yamada, Tomohiko Tsuruta, Kazuto Tasaki, Ryutaro Nishikawa, Shiho Kuji, Takashi Motohashi, Kimihiko Ito, Takashi Yamada, Norihiro Teramoto
KMSID: 1134461 J Gynecol Oncol. 2019;30(6):e103. Published online 2019 July 1 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e103 |
|
e110 |
Reviewer recognition in 2019Reviewer recognition in 2019
KMSID: 1134462 J Gynecol Oncol. 2019;30(6):e110. Published online 2019 November 4 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e110 |
|
e111 |
Comments on: Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective studyComments on: Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study
Thales Paulo Batista, Shigeki KusamuraThales Paulo Batista, Shigeki Kusamura
KMSID: 1134463 J Gynecol Oncol. 2019;30(6):e111. Published online 2019 August 22 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e111 |
|
e112 |
A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-DA phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D
Jung-Yun Lee, Jae Weon Kim, Myong Cheol Lim, Sunghoon Kim, Hee Seung Kim, Chel Hun Choi, Ju Yeon Yi, Sang-Yoon Park, Byoung-Gie Kim, Jung-Yun Lee, Jae Weon Kim, Myong Cheol Lim, Sunghoon Kim, Hee Seung Kim, Chel Hun Choi, Ju Yeon Yi, Sang-Yoon Park, Byoung-Gie Kim,
KMSID: 1134464 J Gynecol Oncol. 2019;30(6):e112. Published online 2019 September 3 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e112 |
|
e113 |
Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint studyNeoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study
Hiroko Machida, Koji Matsuo, Takayuki Enomoto, Mikio MikamiHiroko Machida, Koji Matsuo, Takayuki Enomoto, Mikio Mikami
KMSID: 1134465 J Gynecol Oncol. 2019;30(6):e113. Published online 2019 September 3 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e113 |
|
e114 |
The 61st Annual Meeting of the Japanese Society for Gynecologic Oncology (JSGO)The 61st Annual Meeting of the Japanese Society for Gynecologic Oncology (JSGO)
Kosuke Yoshihara, Masayuki Sekine, Koji Nishino, Takayuki EnomotoKosuke Yoshihara, Masayuki Sekine, Koji Nishino, Takayuki Enomoto
KMSID: 1134466 J Gynecol Oncol. 2019;30(6):e114. Published online 2019 September 2 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e114 |
|
e115 |
ASGO, KSGO, and JSGO announce collaborationASGO, KSGO, and JSGO announce collaboration
KMSID: 1134467 J Gynecol Oncol. 2019;30(6):e115. Published online 2019 November 4 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e115 |
|
e116 |
Which patients benefit from secondary cytoreductive surgery in recurrent ovarian cancer?Which patients benefit from secondary cytoreductive surgery in recurrent ovarian cancer?
Rongyu Zang, Jianqing ZhuRongyu Zang, Jianqing Zhu
KMSID: 1134468 J Gynecol Oncol. 2019;30(6):e116. Published online 2019 September 16 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e116 |
|
e117 |
Fertility sparing treatment for early stage endometrial cancer: current situation and new strategyFertility sparing treatment for early stage endometrial cancer: current situation and new strategy
Kimio UshijimaKimio Ushijima
KMSID: 1134469 J Gynecol Oncol. 2019;30(6):e117. Published online 2019 September 11 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e117 |
|
e118 |
The Annual Meeting of the Thai Gynecologic Cancer Society 2019: Meeting reportThe Annual Meeting of the Thai Gynecologic Cancer Society 2019: Meeting report
Kittipat Charoenkwan, Jatupol SrisomboonKittipat Charoenkwan, Jatupol Srisomboon
KMSID: 1134470 J Gynecol Oncol. 2019;30(6):e118. Published online 2019 September 20 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e118 |
|
e119 |
Therapeutic vaccination using HPV 16 E7 to eradicate CIN3Therapeutic vaccination using HPV 16 E7 to eradicate CIN3
Krishnansu S. TewariKrishnansu S. Tewari
KMSID: 1134471 J Gynecol Oncol. 2019;30(6):e119. Published online 2019 September 20 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e119 |
|
e89 |
Prognostic value of metabolic tumor volume and total lesion glycolysis from 18F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinomaPrognostic value of metabolic tumor volume and total lesion glycolysis from 18F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma
Dou-dou Liu, Jianfang Li, Xiaomao Li, Liangjun Xie, Luping Qin, Fangyu Peng, Mu-hua ChengDou-dou Liu, Jianfang Li, Xiaomao Li, Liangjun Xie, Luping Qin, Fangyu Peng, Mu-hua Cheng
KMSID: 1148324 J Gynecol Oncol. 2019;30(6):e89. Published online 2019 June 11 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e89 |
|
e95 |
Accuracy of frozen section diagnosis and factors associated with final pathological diagnosis upgrade of mucinous ovarian tumorsAccuracy of frozen section diagnosis and factors associated with final pathological diagnosis upgrade of mucinous ovarian tumors
Jeong-Yeol Park, Sang-Hun Lee, Kyu-Rae Kim, Young-Tak Kim, Joo-Hyun NamJeong-Yeol Park, Sang-Hun Lee, Kyu-Rae Kim, Young-Tak Kim, Joo-Hyun Nam
KMSID: 1148325 J Gynecol Oncol. 2019;30(6):e95. Published online 2019 May 20 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e95 |
|
e110 |
Reviewer recognition in 2019Reviewer recognition in 2019
KMSID: 1148314 J Gynecol Oncol. 2019;30(6):e110. Published online 2019 August 20 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e110 |
|
e115 |
ASGO, KSGO, and JSGO announce collaborationASGO, KSGO, and JSGO announce collaboration
KMSID: 1148315 J Gynecol Oncol. 2019;30(6):e115. Published online 2019 September 20 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e115 |
|